Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arteriovenous Malformations | 3 | 2024 | 76 | 1.800 |
Why?
|
| Endothelial Cells | 3 | 2024 | 256 | 1.570 |
Why?
|
| MicroRNAs | 3 | 2023 | 345 | 1.120 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2024 | 51 | 0.910 |
Why?
|
| Subcutaneous Emphysema | 1 | 2023 | 10 | 0.870 |
Why?
|
| Therapeutic Irrigation | 1 | 2023 | 29 | 0.870 |
Why?
|
| Facial Injuries | 1 | 2023 | 25 | 0.860 |
Why?
|
| Wounds, Penetrating | 1 | 2023 | 39 | 0.850 |
Why?
|
| Sphingosine | 4 | 2010 | 28 | 0.840 |
Why?
|
| Hydrogen Peroxide | 1 | 2023 | 112 | 0.840 |
Why?
|
| Lysophospholipids | 4 | 2010 | 44 | 0.830 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2022 | 60 | 0.780 |
Why?
|
| Cell Proliferation | 3 | 2023 | 980 | 0.710 |
Why?
|
| Air Microbiology | 1 | 2020 | 12 | 0.700 |
Why?
|
| Adenoidectomy | 1 | 2020 | 36 | 0.690 |
Why?
|
| Tonsillectomy | 1 | 2020 | 49 | 0.680 |
Why?
|
| Receptors, Notch | 1 | 2020 | 27 | 0.670 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2020 | 54 | 0.670 |
Why?
|
| Surgical Wound Infection | 1 | 2020 | 115 | 0.650 |
Why?
|
| Respiratory Tract Infections | 1 | 2020 | 83 | 0.650 |
Why?
|
| Neovascularization, Pathologic | 1 | 2020 | 155 | 0.640 |
Why?
|
| Hemangioma | 1 | 2020 | 83 | 0.630 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 2018 | 11 | 0.600 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 4 | 2010 | 23 | 0.470 |
Why?
|
| Facial Pain | 1 | 2013 | 9 | 0.440 |
Why?
|
| Central Nervous System Diseases | 1 | 2013 | 26 | 0.430 |
Why?
|
| Sarcoidosis | 1 | 2013 | 44 | 0.410 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2013 | 11 | 0.410 |
Why?
|
| Neck Injuries | 1 | 2013 | 21 | 0.410 |
Why?
|
| Craniocerebral Trauma | 1 | 2013 | 61 | 0.390 |
Why?
|
| Chronic Pain | 1 | 2013 | 183 | 0.350 |
Why?
|
| Electron Transport Complex IV | 1 | 2010 | 28 | 0.350 |
Why?
|
| Mitochondria, Heart | 1 | 2010 | 36 | 0.350 |
Why?
|
| Repressor Proteins | 2 | 2010 | 149 | 0.340 |
Why?
|
| Otolaryngology | 2 | 2022 | 61 | 0.330 |
Why?
|
| Propranolol | 2 | 2020 | 79 | 0.330 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 178 | 0.320 |
Why?
|
| Humans | 17 | 2024 | 50419 | 0.310 |
Why?
|
| Telomere | 1 | 2008 | 35 | 0.290 |
Why?
|
| Child | 5 | 2024 | 6931 | 0.280 |
Why?
|
| Stress, Physiological | 1 | 2008 | 171 | 0.270 |
Why?
|
| Male | 6 | 2024 | 25866 | 0.240 |
Why?
|
| Heart Bypass, Right | 1 | 2024 | 15 | 0.230 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2024 | 90 | 0.220 |
Why?
|
| Arteriovenous Fistula | 1 | 2024 | 30 | 0.220 |
Why?
|
| Infant | 3 | 2024 | 3648 | 0.220 |
Why?
|
| Pulmonary Veins | 1 | 2024 | 41 | 0.220 |
Why?
|
| Blood Proteins | 1 | 2024 | 83 | 0.220 |
Why?
|
| Child, Preschool | 3 | 2024 | 3953 | 0.220 |
Why?
|
| Fontan Procedure | 1 | 2024 | 70 | 0.210 |
Why?
|
| Pulmonary Artery | 1 | 2024 | 153 | 0.200 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2023 | 82 | 0.200 |
Why?
|
| Growth Differentiation Factor 2 | 1 | 2022 | 6 | 0.200 |
Why?
|
| Proteome | 1 | 2024 | 161 | 0.200 |
Why?
|
| RNA, Messenger | 2 | 2022 | 1085 | 0.190 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 134 | 0.190 |
Why?
|
| Proteomics | 1 | 2024 | 313 | 0.190 |
Why?
|
| Adolescent | 2 | 2024 | 6453 | 0.180 |
Why?
|
| Vascular Malformations | 1 | 2022 | 102 | 0.170 |
Why?
|
| Nasopharynx | 1 | 2020 | 33 | 0.170 |
Why?
|
| Hemangioma, Capillary | 1 | 2020 | 12 | 0.170 |
Why?
|
| Ligands | 1 | 2020 | 203 | 0.170 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2020 | 108 | 0.160 |
Why?
|
| Risk | 1 | 2020 | 325 | 0.160 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2020 | 183 | 0.160 |
Why?
|
| Double-Blind Method | 1 | 2020 | 710 | 0.150 |
Why?
|
| Female | 4 | 2024 | 27053 | 0.150 |
Why?
|
| Genetic Markers | 1 | 2018 | 104 | 0.150 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 410 | 0.140 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 948 | 0.140 |
Why?
|
| Transcription Factors | 1 | 2020 | 561 | 0.130 |
Why?
|
| Cohort Studies | 1 | 2020 | 1451 | 0.130 |
Why?
|
| Young Adult | 1 | 2024 | 4075 | 0.120 |
Why?
|
| Pediatrics | 1 | 2018 | 285 | 0.120 |
Why?
|
| Prospective Studies | 1 | 2020 | 2378 | 0.110 |
Why?
|
| Adult | 2 | 2024 | 13561 | 0.110 |
Why?
|
| Paresthesia | 1 | 2013 | 8 | 0.110 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2013 | 7 | 0.110 |
Why?
|
| Signal Transduction | 1 | 2020 | 1608 | 0.110 |
Why?
|
| Infant, Newborn | 1 | 2020 | 2752 | 0.100 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2013 | 102 | 0.100 |
Why?
|
| Risk Factors | 1 | 2020 | 3712 | 0.100 |
Why?
|
| Wound Healing | 1 | 2013 | 183 | 0.090 |
Why?
|
| Mandible | 1 | 2012 | 27 | 0.090 |
Why?
|
| Cell Line | 2 | 2010 | 997 | 0.090 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2010 | 3 | 0.090 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2010 | 5 | 0.080 |
Why?
|
| Sphingolipids | 1 | 2010 | 15 | 0.080 |
Why?
|
| Extracellular Space | 1 | 2010 | 40 | 0.080 |
Why?
|
| Intracellular Space | 1 | 2010 | 25 | 0.080 |
Why?
|
| Mammals | 1 | 2010 | 50 | 0.080 |
Why?
|
| Arabidopsis | 1 | 2010 | 23 | 0.080 |
Why?
|
| Oxygen Consumption | 1 | 2010 | 191 | 0.080 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2010 | 93 | 0.080 |
Why?
|
| Middle Aged | 1 | 2024 | 12579 | 0.080 |
Why?
|
| Myocytes, Cardiac | 1 | 2010 | 122 | 0.080 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 575 | 0.080 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2010 | 173 | 0.080 |
Why?
|
| Cell Nucleus | 1 | 2009 | 183 | 0.080 |
Why?
|
| Metals, Heavy | 1 | 2008 | 6 | 0.070 |
Why?
|
| Retrospective Studies | 1 | 2020 | 6274 | 0.070 |
Why?
|
| Telomerase | 1 | 2008 | 25 | 0.070 |
Why?
|
| Molecular Chaperones | 1 | 2008 | 59 | 0.070 |
Why?
|
| Mice, Knockout | 1 | 2010 | 840 | 0.070 |
Why?
|
| Histones | 1 | 2009 | 294 | 0.070 |
Why?
|
| Animals | 3 | 2010 | 13063 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 1546 | 0.070 |
Why?
|
| Fibroblasts | 1 | 2008 | 338 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 1796 | 0.060 |
Why?
|
| Cells, Cultured | 1 | 2008 | 1563 | 0.060 |
Why?
|
| Mice | 2 | 2010 | 5659 | 0.050 |
Why?
|
| Genetic Testing | 1 | 2022 | 120 | 0.050 |
Why?
|
| LIM Domain Proteins | 1 | 2020 | 8 | 0.040 |
Why?
|
| Retinal Dehydrogenase | 1 | 2020 | 10 | 0.040 |
Why?
|
| Myosin Type I | 1 | 2020 | 5 | 0.040 |
Why?
|
| Antiporters | 1 | 2020 | 19 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2020 | 47 | 0.040 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 39 | 0.040 |
Why?
|
| Mitochondrial Proteins | 1 | 2020 | 87 | 0.040 |
Why?
|
| Lysine | 2 | 2010 | 84 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 200 | 0.040 |
Why?
|
| Heart Defects, Congenital | 1 | 2024 | 603 | 0.040 |
Why?
|
| Transcriptome | 1 | 2020 | 314 | 0.040 |
Why?
|
| Mitochondria | 1 | 2020 | 400 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 1020 | 0.030 |
Why?
|
| Apoptosis | 1 | 2020 | 1092 | 0.030 |
Why?
|
| Ilium | 1 | 2012 | 8 | 0.020 |
Why?
|
| United States | 1 | 2022 | 5005 | 0.020 |
Why?
|
| Scapula | 1 | 2012 | 16 | 0.020 |
Why?
|
| Fibula | 1 | 2012 | 23 | 0.020 |
Why?
|
| Dental Implants | 1 | 2012 | 26 | 0.020 |
Why?
|
| Bone Transplantation | 1 | 2012 | 43 | 0.020 |
Why?
|
| Biocompatible Materials | 1 | 2012 | 66 | 0.020 |
Why?
|
| Free Tissue Flaps | 1 | 2012 | 63 | 0.020 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2010 | 6 | 0.020 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2010 | 6 | 0.020 |
Why?
|
| I-kappa B Proteins | 1 | 2010 | 14 | 0.020 |
Why?
|
| I-kappa B Kinase | 1 | 2010 | 19 | 0.020 |
Why?
|
| Biocatalysis | 1 | 2010 | 13 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2010 | 42 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2010 | 190 | 0.020 |
Why?
|
| Histone Deacetylase 2 | 1 | 2009 | 3 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2010 | 268 | 0.020 |
Why?
|
| Histone Deacetylase 1 | 1 | 2009 | 8 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 241 | 0.020 |
Why?
|
| Nucleosomes | 1 | 2009 | 11 | 0.020 |
Why?
|
| Genes, fos | 1 | 2009 | 28 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2009 | 47 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2009 | 57 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2009 | 68 | 0.020 |
Why?
|
| Acetylation | 1 | 2009 | 94 | 0.020 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2009 | 56 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2010 | 333 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2009 | 51 | 0.020 |
Why?
|
| RNA Interference | 1 | 2009 | 179 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2010 | 520 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2010 | 306 | 0.020 |
Why?
|
| Protein Binding | 1 | 2010 | 648 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 386 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2009 | 455 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2009 | 371 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 1393 | 0.020 |
Why?
|